Rapid molecular point of care testing
Active Awarded Last action
- Contract number
- 36C25926N0224
- Awardee
-
Roche Diagnostics Corporation UEI JDMDFEZBYH36
- Awarding agency
-
Veterans Integrated Service Network 19
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $441,830
Award facts
- Contract value 100% obligated
- $441,830.00 Current and potential, with all options
- Completion date 72% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 334516 Analytical Laboratory Instrument Manufacturing
- Set-aside
- No set-aside
- Competition
- Competed under SAP · 4 offers Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Oklahoma City, OK 73104, USA
Award details come from SAM.gov/FPDS.
About this award
Roche Diagnostics Corporation received a $441,830 firm fixed-price BPA (Blanket Purchase Agreement) call order from Veterans Integrated Service Network 19 (VISN 19), a civilian component of the Department of Veterans Affairs, to provide rapid molecular point-of-care testing services. The contract, awarded on February 1, 2026, will be performed in Oklahoma City, Oklahoma, with an ultimate completion date of January 31, 2027. This award represents a child contract under an existing indefinite delivery vehicle, enabling VISN 19 to access pre-negotiated pricing and established terms for molecular diagnostic testing capabilities that support veterans' healthcare delivery across the network.
As a foreign-owned manufacturer headquartered in Indianapolis, Indiana, Roche Diagnostics Corporation is a global leader in in vitro diagnostics and laboratory instruments with an extensive federal contracting presence across the Department of Veterans Affairs, Defense Health Agency, and other civilian healthcare entities. The company's federal portfolio includes COBAS molecular diagnostic analyzers, point-of-care testing devices, and comprehensive diagnostic reagents and supplies. This contract continues Roche's established relationship with VISN 19, which maintains a pre-existing BPA for point-of-care PT/INR analyzer services. The award was made without set-aside designation, reflecting open competition in the federal marketplace, and carries no subcontracting requirements based on the information provided.
Quick answers
Who was awarded contract 36C25926N0224?
36C25926N0224 was awarded to Roche Diagnostics Corporation by Veterans Integrated Service Network 19 (Veterans Health Administration) on February 1, 2026.
How much is contract 36C25926N0224 worth?
The government has obligated $441,830 on 36C25926N0224.
Is contract 36C25926N0224 an order under another contract?
Yes. 36C25926N0224 is a BPA call under 36C25924A0042, a blanket purchase agreement.
Was contract 36C25926N0224 competed?
The extent of competition for 36C25926N0224 was competed under sap. The government received 4 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award